DNA synthesis technology allows the production of long, pure DNA sequences to support the needs of scientific research. DNA Synthesizers are used to chemically produce (synthesize) DNA strands through an automated process and are a crucial part of the tools used in molecular biology, biochemistry and genetics labs. They enable researchers to design and synthesize customized genes and DNA/RNA fragments for applications such as functional genomics, molecular cloning, next generation sequencing library preparation, and molecular diagnostic development. With growing R&D investments in biotechnology and pharmaceutical sectors, the demand for DNA Synthesizers is increasing significantly as DNA synthesis provides a cost-effective method for assembling genes and genomes as compared to conventional cloning techniques.
The global DNA Synthesizer Market is estimated to be valued at US$ 4.3 Bn in 2023 and is expected to exhibit a CAGR of 20% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Get more insights on this topic: https://www.coherentmarketinsights.com/market-insight/dna-synthesizer-market-5913
Market key trends:
One of the key trends in the DNA Synthesizer market is the shift towards gene synthesis from gene cloning. Earlier long DNA sequences used to be generated via gene cloning which involved multiple manual steps and took weeks to produce. However, with advances in DNA synthesis technology, genes can now be rapidly synthesized through an automated process in a matter of days. Gene synthesis provides advantages such as time and cost savings as compared to gene cloning. It allows designing genes from scratch and incorporating modifications easily. Owing to these benefits, many government agencies and pharma companies are outsourcing their gene synthesis needs to DNA synthesis companies. This trend is expected to significantly drive the demand for DNA synthesizers during the forecast period. Another important trend is the development of new technologies that enable faster, large-scale, and low-cost DNA synthesis. Companies are focusing on developing innovative solutions that can synthesizes kilobases and megabase-scale DNA, which will further accelerate research and discovery applications of synthetic biology.
Porter’s Analysis
Threat of new entrants: The threat of new entrants in the DNA synthesizer market is relatively low due to the requirement of high capital investment and technology for synthesizer equipment.
Bargaining power of buyers: The bargaining power of buyers is moderate as DNA synthesizer equipment has applications across biotechnology and pharmaceutical industries.
Bargaining power of suppliers: The bargaining power of suppliers is low owing to the availability of component suppliers for DNA synthesizer equipment.
Threat of new substitutes: There is no direct substitute for DNA synthesizer equipment currently used for DNA synthesis in research and development activities.
Competitive rivalry: The DNA synthesizer market exhibits strong competitive rivalry among existing key players due to their technological expertise and global presence.
Key Takeaways
The global DNA Synthesizer Market is expected to witness high growth.
Regional analysis related content comprises the North America region dominates the global DNA synthesizer market Currently, accounting for the largest market share owing to growing biotechnology and pharmaceutical industries in the US and Canada.
Key players operating in the DNA Synthesizer market are Thermo Fisher Scientific, Merck KGaA, Agilent Technologies, Danaher Corporation (Integrated DNA Technologies), GenScript Biotech Corporation, Eurofins Genomics, LGC Limited, BioAutomation Corporation, Bio-Rad Laboratories, Twist Bioscience Corporation, Hamilton Company, New England Biolabs, Nippon Genetics, LGC Biosearch Technologies, DNA Script, Ribbon Biolabs GmbH, and Camena Bioscience. These players are focusing on new product launches and expansion strategies to gain more revenue share in the DNA synthesizer market.
